# Corning Incorporated – Consensus ‘buy’ rating and -5.5% Downside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-consensus-buy-rating-and-5.5-downside-potential/4121165686
- Published: 2024-07-22T13:27:05+01:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) have now 13 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The target
price High/Low ranges between $51.00 and $33.50 suggesting an average Analsyt target
price of $42.50. Now with the previous closing price of $44.99 this now indicates
there is a potential downside of -5.5%. Also worth taking note is the 50 day moving
average now sits at $38.99 and the 200 moving average now moves to $32.77. The company
has a market cap of 37.96B. The stock price for Occidental Petroleum Corporation
is $44.31 USD

 The potential market cap would be $35,856,045,777 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 61.54, revenue per share of $14.57
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on: